<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00181753</url>
  </required_header>
  <id_info>
    <org_study_id>2P50GM021700-27A1</org_study_id>
    <secondary_id>2004-P-001946</secondary_id>
    <nct_id>NCT00181753</nct_id>
  </id_info>
  <brief_title>Study of Glutamate and Glutamine Metabolism in Burn Patients Receiving Enteral or Parenteral Nutrition</brief_title>
  <official_title>Study of Glutamate and Glutamine Metabolism in Burn Patients Receiving Enteral or Parenteral Nutrition</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Massachusetts General Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institutes of Health (NIH)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>National Institute of General Medical Sciences (NIGMS)</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study is to understand how the body uses amino acids in burned patients
      during the time they cannot eat normally. Amino acids occur naturally in the body and the
      food we eat. The body combines amino acids to make protein. It uses the proteins to do things
      such as heal wounds, fight infection, and provide energy. We are studying two ways of
      receiving nutrition: through a vein or through a tube. We are also studying two different
      types of food: with or without glutamine. The results of this study will be used to determine
      the best type and way to supply nutrients during a severe burn injury. We hope to learn how
      to help the body use nutrients more efficiently to better repair wounded tissues and recover
      earlier from injury.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      We hypothesize that:

        1. Burn patients will experience an increased conversion of glutamine to glutamate and a
           decreased conversion of glutamate to glutamine as compared to healthy subjects. The net
           direction is from glutamine to glutamate in burn patients and would render glutamine as
           a conditionally essential amino acid.

        2. Because of the limited ability of liver to oxidize glutamate, it is possible that large
           doses of glutamine may cause increased gluconeogenesis in burn patients, thus
           aggravating the glucose homeostasis secondary to insulin resistance.

        3. Enterally and parenterally fed glutamine and glutamate have different metabolic fate in
           the splanchnic bed and peripheral regions, therefore the doses should be tailored
           according to the route of administration.

      This study, using stable isotope tracers, aims to track the metabolic fate of glutamine and
      glutamate in body with the goal of enhancing nutritional efficiency.
    </textblock>
  </detailed_description>
  <overall_status>Withdrawn</overall_status>
  <why_stopped>
    State of Mass. tightened regulations for making intravenous solutions for research subjects.
    Study was withdrawn and no participants were enrolled.
  </why_stopped>
  <start_date>November 2009</start_date>
  <completion_date type="Anticipated">October 2010</completion_date>
  <primary_completion_date type="Anticipated">October 2010</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>This is a nutritional study. The primary outcome is to measure the protein kinetics for metabolism of the amino acid, glutamate and glutamine. Fate will be determine from measurements of subject blood and air samples.</measure>
    <time_frame>3 days and above</time_frame>
  </primary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">0</enrollment>
  <condition>Burns</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Burn Patients receiving at least 3 days of parenteral feeding on routine formula</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Burn patients receiving at least 3 days on parenteral feeding on glutamine enriched formula.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>3</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Burn patients receiving at least 3 days of enteral feeding on routine formula.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>4</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Burn patients receiving at least 3 days of enteral feeding on glutamine-enriched formula.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>standard vs. glutamine enteral or parenteral feeding.</intervention_name>
    <description>Patient in each group will continue on the same diet for &gt; 3 days before we conduct stable isotope tracer measurements.</description>
    <arm_group_label>1</arm_group_label>
    <arm_group_label>2</arm_group_label>
    <arm_group_label>3</arm_group_label>
    <arm_group_label>4</arm_group_label>
    <other_name>Nutritional Support</other_name>
    <other_name>Glutamine</other_name>
    <other_name>Glutamate</other_name>
    <other_name>Amino Acide</other_name>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Stable isotope tracer study</intervention_name>
    <description>7 hours of primed constant infusion</description>
    <arm_group_label>1</arm_group_label>
    <arm_group_label>2</arm_group_label>
    <arm_group_label>3</arm_group_label>
    <arm_group_label>4</arm_group_label>
    <other_name>Glutamine</other_name>
    <other_name>Stable isotope study</other_name>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Stable isotope study</intervention_name>
    <description>7 hours of primed constant infusion of stable isotope tracers.</description>
    <arm_group_label>1</arm_group_label>
    <arm_group_label>2</arm_group_label>
    <arm_group_label>3</arm_group_label>
    <arm_group_label>4</arm_group_label>
    <other_name>Stable isotopes</other_name>
    <other_name>Glutamine</other_name>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Stable isotope tracer study</intervention_name>
    <description>7 hours of primed constant stable isotope tracer infusion.</description>
    <arm_group_label>1</arm_group_label>
    <arm_group_label>2</arm_group_label>
    <arm_group_label>3</arm_group_label>
    <arm_group_label>4</arm_group_label>
    <other_name>Stable isotope tracers</other_name>
    <other_name>Glutamine</other_name>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Stable isotope tracer study</intervention_name>
    <description>7 hours primed constant infusion of stable isotope tracer study</description>
    <arm_group_label>1</arm_group_label>
    <arm_group_label>2</arm_group_label>
    <arm_group_label>3</arm_group_label>
    <arm_group_label>4</arm_group_label>
    <other_name>Glutamine</other_name>
    <other_name>Stable isotope tracers</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  One or more of the following:

               -  5% Total Body Surface Area Thermal Burn

          -  Inhalation Injury

          -  Resting Energy Expenditure of &gt;15% of the predicted Basal Metabolic Rate Using
             Harris-Benedict.

          -  Receiving Enteral or Parental Nutritional Support

        Exclusion Criteria:

          -  Pre-existing:

          -  Thyroid disease

          -  Congestive Heart Failure (Ejection fraction &lt;20%)

          -  Malignancy currently under treatment

          -  Medical conditions requiring glucocorticoid treatment

          -  Decision not to treat because of severity of injury

          -  Presence of Anoxic brain injury with no expectation for recovery

          -  Self-Inflicted thermal injury

          -  Ileus, gut paralysis, or facial injuries

          -  No NG or OG tube as part of their clinical care
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ronald G Tompkins, MD, ScD</last_name>
    <role>Principal Investigator</role>
    <affiliation>MGH, Shriners Burn Hospital-Boston</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Massachusetts General Hospital Burn Unit</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02114</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://burnresearchcenter.org</url>
  </link>
  <reference>
    <citation>Sheridan RL, Prelack K, Yu YM, Lydon M, Petras L, Young VR, Tompkins RG. Short-term enteral glutamine does not enhance protein accretion in burned children: a stable isotope study. Surgery. 2004 Jun;135(6):671-8.</citation>
    <PMID>15179374</PMID>
  </reference>
  <reference>
    <citation>Young VR, Ajami AM. Glutamine: the emperor or his clothes? J Nutr. 2001 Sep;131(9 Suppl):2449S-59S; discussion 2486S-7S. doi: 10.1093/jn/131.9.2449S. Review.</citation>
    <PMID>11533293</PMID>
  </reference>
  <reference>
    <citation>Herndon DN, Tompkins RG. Support of the metabolic response to burn injury. Lancet. 2004 Jun 5;363(9424):1895-902. Review.</citation>
    <PMID>15183630</PMID>
  </reference>
  <verification_date>January 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 13, 2005</study_first_submitted>
  <study_first_submitted_qc>September 13, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 16, 2005</study_first_posted>
  <last_update_submitted>January 12, 2017</last_update_submitted>
  <last_update_submitted_qc>January 12, 2017</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 13, 2017</last_update_posted>
  <responsible_party>
    <name_title>Ronald G. Tompkins, MD, ScD, Chief, Burn Service</name_title>
    <organization>Massachusetts General Hospital</organization>
  </responsible_party>
  <keyword>glutamine metabolic kinetics</keyword>
  <keyword>glutamate metabolic kinetics</keyword>
  <keyword>enteral nutrition</keyword>
  <keyword>parenteral nutrition</keyword>
  <keyword>burn injury</keyword>
  <keyword>stable isotopes</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Burns</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

